Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement.

ABSTRACT:

Importance

The 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline concluded that obesity alone should not delay joint replacement. Therefore, a substantially increased utilization of joint replacement among patients with obesity could be expected. However, patients with obesity are at increased risk of revision, posing unique challenges as the surgery is complex and costly, and it remains unknown whether postoperative weight loss could decrease the risk of revision.

Objective

To examine the association of the proportion of postoperative weight loss following antiobesity medication use with the risk of revision among patients with obesity undergoing hip or knee replacement.

Design, setting, and participants</

SUBMITTER: Xie D 

PROVIDER: S-EPMC11846009 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature